Earnings Labs
Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc. (APLS) Earnings

NASDAQ·Healthcare·Biotechnology

$40.95

+0.00%

Mkt Cap $5.23B

Next Earnings

In 7 days

Wed, May 6, 2026

EPS Estimate

-$0.38

10 analysts

Revenue Estimate

$203.58M

Last quarter: missed by -20.51% on EPS, +0.26% on revenue.

EPS — Estimate vs Actual

Mkt Cap

$5.23B

P/E

240.82

Fwd P/E

72.59

P/S

5.21

Rev TTM

EPS TTM

$0.17